ENDONOVO THERAPEUTICS, INC. (ENDV) Net income 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$18.5MFY2022 · since FY2013: -$2.9M → -$18.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$18.5M | -495.0% |
| FY2021 | -$3.1M | -684.9% |
| FY2020 | -$395,584 | +97.7% |
| FY2019 | -$17.3M | -169.0% |
| FY2018 | -$6.4M | +40.5% |
| FY2017 | -$10.8M | -103.4% |
| FY2016 | -$5.3M | +21.4% |
| FY2015 | -$6.8M | -605.1% |
| FY2014 | -$959,494 | +66.8% |
| FY2013 | -$2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice